895 related articles for article (PubMed ID: 19703355)
21. Anxiolytic-like actions of leaves of Casimiroa edulis (Rutaceae) in male Wistar rats.
Molina-Hernández M; Tellez-Alcántara NP; García JP; Lopez JI; Jaramillo MT
J Ethnopharmacol; 2004 Jul; 93(1):93-8. PubMed ID: 15182911
[TBL] [Abstract][Full Text] [Related]
22. Possible anxiolytic effects of taurine in the mouse elevated plus-maze.
Chen SW; Kong WX; Zhang YJ; Li YL; Mi XJ; Mu XS
Life Sci; 2004 Aug; 75(12):1503-11. PubMed ID: 15240184
[TBL] [Abstract][Full Text] [Related]
23. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors.
Peng WH; Wu CR; Chen CS; Chen CF; Leu ZC; Hsieh MT
Life Sci; 2004 Oct; 75(20):2451-62. PubMed ID: 15350820
[TBL] [Abstract][Full Text] [Related]
24. Anxiolytic-like effect of paeonol in mice.
Mi XJ; Chen SW; Wang WJ; Wang R; Zhang YJ; Li WJ; Li YL
Pharmacol Biochem Behav; 2005 Jul; 81(3):683-7. PubMed ID: 15970315
[TBL] [Abstract][Full Text] [Related]
25. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats.
Umathe SN; Bhutada PS; Jain NS; Dixit PV; Wanjari MM
Behav Pharmacol; 2008 Jul; 19(4):308-16. PubMed ID: 18622178
[TBL] [Abstract][Full Text] [Related]
26. Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice.
Grundmann O; Nakajima J; Kamata K; Seo S; Butterweck V
Phytomedicine; 2009 Apr; 16(4):295-302. PubMed ID: 19303276
[TBL] [Abstract][Full Text] [Related]
27. Animal model of anxiety: effect of chronic diazepam treatment in the genetically hypertensive rats of Koletsky type and in the rats of Wistar strain.
Golda V; Petr R
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1990; 33(2):165-75. PubMed ID: 2098905
[TBL] [Abstract][Full Text] [Related]
28. Free and Easy Wanderer Plus (FEWP), a polyherbal preparation, ameliorates PTSD-like behavior and cognitive impairments in stressed rats.
Wang HN; Peng Y; Tan QR; Wang HH; Chen YC; Zhang RG; Wang ZZ; Guo L; Liu Y; Zhang ZJ
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1458-63. PubMed ID: 19665511
[TBL] [Abstract][Full Text] [Related]
29. An approach to evaluate the ability of rats to discriminate different levels of illumination in the plus maze test: effects of scopolamine.
de Araújo Godinho MA; Meneghini L; Lucinda AM; Borges FR; Sakae DY; Marino Neto J; Paschoalini MA; de Lima TC; Faria MS
Behav Brain Res; 2007 Jun; 180(1):86-94. PubMed ID: 17408761
[TBL] [Abstract][Full Text] [Related]
30. The effects of angelica essential oil in three murine tests of anxiety.
Chen SW; Min L; Li WJ; Kong WX; Li JF; Zhang YJ
Pharmacol Biochem Behav; 2004 Oct; 79(2):377-82. PubMed ID: 15501315
[TBL] [Abstract][Full Text] [Related]
31. The effects of the intraamygdalar melatonin injections on the anxiety like behavior and the spatial memory performance in male Wistar rats.
Karakaş A; Coşkun H; Kaya A; Kücük A; Gündüz B
Behav Brain Res; 2011 Sep; 222(1):141-50. PubMed ID: 21421010
[TBL] [Abstract][Full Text] [Related]
32. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam.
Ochoa-Sanchez R; Rainer Q; Comai S; Spadoni G; Bedini A; Rivara S; Fraschini F; Mor M; Tarzia G; Gobbi G
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):318-25. PubMed ID: 22789661
[TBL] [Abstract][Full Text] [Related]
33. Variations in illumination, closed wall transparency and/or extramaze space influence both baseline anxiety and response to diazepam in the rat elevated plus-maze.
Violle N; Balandras F; Le Roux Y; Desor D; Schroeder H
Behav Brain Res; 2009 Oct; 203(1):35-42. PubMed ID: 19389429
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to S100 proteins have anxiolytic-like activity at ultra-low doses in the adult rat.
Castagne V; Lemaire M; Kheyfets I; Dugina JL; Sergeeva SA; Epstein OI
J Pharm Pharmacol; 2008 Mar; 60(3):309-16. PubMed ID: 18284810
[TBL] [Abstract][Full Text] [Related]
35. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice.
Vargas KM; Da Cunha C; Andreatini R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1394-402. PubMed ID: 16828217
[TBL] [Abstract][Full Text] [Related]
36. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
37. Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice.
Carrasco MC; Vicens P; Vidal J; Redolat R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):455-62. PubMed ID: 16413646
[TBL] [Abstract][Full Text] [Related]
38. Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats.
Martijena ID; Bustos SG; Bertotto ME; Molina VA
Eur Neuropsychopharmacol; 2005 Jan; 15(1):119-30. PubMed ID: 15572281
[TBL] [Abstract][Full Text] [Related]
39. Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze.
Stern CA; Carobrez AP; Bertoglio LJ
Pharmacol Biochem Behav; 2008 Oct; 90(4):545-50. PubMed ID: 18533241
[TBL] [Abstract][Full Text] [Related]
40. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
